Investigation on the use of hydrolysed ribonucleic acid (RNA) dissolving microneedle patch versus silicone sheets on appearance of post-surgical scars

Not Applicable

• Conditions: Hypertrophic scarring; Post-surgical scarring; Skin - Dermatological conditions; Surgery - Other surgery

• Registration Number: ACTRN12622000558729
• Lead Sponsor: A/Prof Tey Hong Liang

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-04-12
• Last Update Posted: 19 April 2022

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 54

Inclusion Criteria

The inclusion criteria would be:
a.Adult
b.Age 21-75
c.2 weeks (+/- 3 days) after surgical operation with incision requiring stitches
d.Post-stitch removal
e.Wound closure/union achieved

Exclusion Criteria

The exclusion criteria would include:
a.Pregnant or lactating participants
b.Participants with wound infection
c.Participants assessed to be uncooperative or unable to self-administer the interventions
d.Participants with known contact allergy to ingredients in the patch formulation (comprising hyaluronic acid, hydrolysed RNA and glue), isopropyl alcohol, and/or silicone

Study & Design

• Study Type: Interventional
• Study Design: Not specified